Full-Time

Scientist – R&D

Confirmed live in the last 24 hours

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions provider

Biotechnology
Healthcare

Compensation Overview

$108.8k - $135.9kAnnually

Mid

San Carlos, CA, USA

Hybrid position requiring in-office work in San Carlos, CA.

Category
Lab & Research
Medical Research
Required Skills
Python
R
Data Analysis
Excel/Numbers/Sheets
Requirements
  • Ph.D. or equivalent in molecular biology, genomics, or a closely related discipline
  • A minimum of 2 years of industry or postdoctoral research experience post-Ph.D.
  • Hands-on experience with next-generation sequencing (NGS) technologies and sample preparation methods, including DNA/RNA extraction, library preparation, multiplex PCR, and hybrid capture
  • Strong research skills with a track record of designing and implementing innovative molecular assay methods
  • Past experience with research and/or development of NGS assays for oncology applications is a plus
  • Skilled in data analysis and statistical testing using tools such as Excel, JMP, R, or Python
  • Proven success in independently executing project assignments and collaborating effectively within a team environment
  • Able to draft clear project plans, study protocols, and standard operating procedures
Responsibilities
  • Participate in the design and execution of research projects focused on designing and demonstrating the feasibility of novel nucleic acid based diagnostic tests
  • Leads the planning and execution of defined assignments while contributing to the definition and refinement of overall project plans
  • Plans and performs complex laboratory experiments following Good Laboratory Practice
  • Analyzes data to generate actionable insights
  • Synthesizes findings and communicates results to project teams and provides regular updates at departmental meetings
  • Proposes, investigates, and implements solutions to advance research objectives and address technical challenges

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

10%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
  • AI integration enhances accuracy and speed of Natera's cfDNA analysis.
  • Growing personalized medicine trend aligns with Natera's customized genetic tests.

What critics are saying

  • Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
  • New Prospera Heart features may face slow adoption by healthcare providers.
  • Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

What makes Natera unique

  • Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
  • Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
  • Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks